Pneumomediastinum as a complication of SABR for lung metastases

Conclusion:
Radiation oncologist should be aware of the potential risk of severe lung toxicity caused by SABR in patients with ILD, especially when chemotherapy-induced pulmonary toxicity is administered in a short time interval.

Source: Epidemiologic Perspectives and Innovations - January 23, 2015 Category: Epidemiology Authors: María Rodríguez-RuizEstefanía ArévaloIgnacio Gil-BazoAlicia GarcíaGerman ValtueñaMarta Moreno-JiménezLeire Arbea-MorenoJavier Mendioroz Source Type: research